AI
Alphabet Inc Portfolio holdings
AUM
$2.14B
This Quarter Return
-21.5%
1 Year Return
+56.95%
3 Year Return
+189.16%
5 Year Return
+193.61%
10 Year Return
+303.91%
AUM
$3.08B
AUM Growth
+$3.08B
(-26%)
Cap. Flow
+$117M
Cap. Flow
% of AUM
3.81%
Top 10 Holdings %
Top 10 Hldgs %
78.16%
Holding
61
New
3
Increased
3
Reduced
6
Closed
1
Top Buys
| 1 |
DexCom
DXCM
|
$177M |
| 2 |
Snowflake
SNOW
|
$123M |
| 3 |
Rani Therapeutics
RANI
|
$9.65M |
| 4 |
BHIL
Benson Hill, Inc.
BHIL
|
$1.94M |
| 5 |
HLTH
Cue Health Inc. Common Stock
HLTH
|
$174K |
Top Sells
| 1 |
Toast
TOST
|
$175M |
| 2 |
Vera Therapeutics
VERA
|
$9.68M |
| 3 |
SentinelOne
S
|
$4.54M |
| 4 |
Uber
UBER
|
$2.07M |
| 5 |
RAPT Therapeutics
RAPT
|
$1.92M |
Sector Composition
| 1 | Healthcare | 53.88% |
| 2 | Technology | 34.52% |
| 3 | Industrials | 7.5% |
| 4 | Financials | 2.21% |
| 5 | Consumer Staples | 1.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
DexCom
DXCM
$29.5B
| $537M | 17.44% | 1,050,595 +346,584 | +49% | +$177M |
|
2
UiPath
PATH
$5.95B
| $304M | 9.86% | 14,068,674 | – | – |
|
3
IonQ
IONQ
$12.7B
| $280M | 9.07% | 21,907,038 | – | – |
|
|
VERV
4
DELISTED
Verve Therapeutics
VERV
| $250M | 8.13% | 10,974,011 | – | – |
|
5
Oscar Health
OSCR
$4.31B
| $240M | 7.78% | 24,042,864 | – | – |
|
6
Lyft
LYFT
$6.73B
| $236M | 7.65% | 6,138,154 | – | – |
|
|
EQRX
7
DELISTED
EQRx, Inc. Common Stock
EQRX
| $196M | 6.37% | 47,552,687 | – | – |
|
8
Planet Labs
PL
$2.15B
| $162M | 5.27% | 31,942,641 | – | – |
|
|
9
Snowflake
SNOW
$79.6B
| $123M | 3.98% | +535,604 | New | +$123M |
|
10
Arcus Biosciences
RCUS
$1.13B
| $80.9M | 2.63% | 2,563,441 | – | – |
|
11
Freshworks
FRSH
$3.93B
| $72.3M | 2.35% | 4,035,595 | – | – |
|
12
Robinhood
HOOD
$92.4B
| $66.6M | 2.16% | 4,928,535 | – | – |
|
|
DM
13
DELISTED
Desktop Metal, Inc.
DM
| $52.4M | 1.7% | 11,048,730 | – | – |
|
|
BHIL
14
DELISTED
Benson Hill, Inc.
BHIL
| $49.6M | 1.61% | 15,352,271 +600,000 | +4% | +$1.94M |
|
15
Relay Therapeutics
RLAY
$619M
| $47M | 1.52% | 1,568,753 +4,580 | +0.3% | +$137K |
|
|
16
Toast
TOST
$26.3B
| $31.1M | 1.01% | 1,432,660 -8,064,224 | -85% | -$175M |
|
17
Lyell Immunopharma
LYEL
$213M
| $29.6M | 0.96% | 5,865,125 | – | – |
|
18
Invivyd
IVVD
$204M
| $25.9M | 0.84% | 5,680,785 | – | – |
|
|
ME
19
DELISTED
23andMe Holding Co. Class A Common Stock
ME
| $25.8M | 0.84% | 6,736,785 | – | – |
|
20
Sana Biotechnology
SANA
$777M
| $23.2M | 0.75% | 2,812,500 | – | – |
|
21
Monte Rosa Therapeutics
GLUE
$296M
| $20.5M | 0.67% | 1,464,015 | – | – |
|
22
Illumina
ILMN
$15.8B
| $18.7M | 0.61% | 53,470 | – | – |
|
23
Beam Therapeutics
BEAM
$1.66B
| $18.4M | 0.6% | 321,604 | – | – |
|
|
SNCE
24
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
| $17.3M | 0.56% | 3,241,075 | – | – |
|
|
ENJY
25
DELISTED
Enjoy Technology, Inc. Common Stock
ENJY
| $16.5M | 0.54% | 4,345,340 | – | – |
|